Jacob Vincent Micallef, Chief Scientific Officer at VOLITIONRX LTD (VNRX), bought 20,000 shares at $1.24 ($25K) on 2023-08-25, disclosed to the SEC on 2023-08-28.
Open-market purchase of $25k VNRX by Chief Scientific Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Nothing distinguishes this filing.
| Filing → |
| VNRX | BUY | 2023-08-31 | $25K | — | Filing → |
| VNRX | BUY | 2022-12-20 | $129K | — | Filing → |
| VNRX | BUY | 2022-09-20 | $22K | — | Filing → |